Funding and Research Opportunities

The following funding opportunity announcements from the NHLBI or other components of the National Institutes of Health, might be of interest:

Notices

The National Institutes of Health (NIH) Sexual & Gender Minority Research Office (SGMRO) Announces Southern Regional Workshop on Sexual and Gender Minority (SGM)-Related Research (NOT-OD-19-097) National Institutes of Health

Notification of Upcoming Change in Federal-wide Unique Entity Identifier Requirements

(NOT-OD-19-098) National Institutes of Health

Notice of Change to Eligibility Information and Key Dates in RFA-HL-20-009 "BLOODSAFE (UG3/UH3 Clinical Trial Optional)" and Announcement of Availability of FAQs

(NOT-HL-19-691) National Heart, Lung, and Blood Institute

Pre-Submission Technical Assistance Webinar and Frequently Asked Questions for RFA-HL-20-003: "Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) (UG3/UH3 Clinical Trial Optional)

(NOT-HL-19-692) National Heart, Lung, and Blood Institute

Pre-Submission Technical Assistance Webinar and Frequently Asked Questions for RFA-HL-20-004 "Disparities Elimination through Coordinated Interventions to Prevent and Control Heart and Lung Disease Risk (DECIPHeR) Research Coordinating Center (U24)"

(NOT-HL-19-693) National Heart, Lung, and Blood Institute

Notice of Change to Key Dates in RFA-HL-20-010 "BLOODSAFE (U24 Clinical Trial Not Allowed)"

(NOT-HL-19-694) National Heart, Lung, and Blood Institute

Requests for Applications

Late-Stage Implementation Research Addressing Hypertension in Low- and Middle-Income Countries: Scaling Up Proven-Effective Interventions (UG3/UH3 Clinical Trial Optional)

(RFA-HL-20-005) National Heart, Lung, and Blood Institute